Biophysics

E.F. Pai, W. Kabsch, U. Krengel, K.C. Holmes, et al., "Structure of the guanine-nucleotide-binding domain of the Ha-ras oncogene product p21 in the triphosphate conformation," Nature, 341, 209-14, 21 September 1989. Emil F. Pai (Max-Planck-Institut für Medizinische Forschung, Heidelberg, Germany): "The best way to have one's paper featured in the `Hot Papers' section is to work in a `hot' field of research. At this moment, there is barely any `hotter' field than oncogenes in cancer resear

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

E.F. Pai, W. Kabsch, U. Krengel, K.C. Holmes, et al., "Structure of the guanine-nucleotide-binding domain of the Ha-ras oncogene product p21 in the triphosphate conformation," Nature, 341, 209-14, 21 September 1989.

Emil F. Pai (Max-Planck-Institut für Medizinische Forschung, Heidelberg, Germany): "The best way to have one's paper featured in the `Hot Papers' section is to work in a `hot' field of research. At this moment, there is barely any `hotter' field than oncogenes in cancer research. Moreover, a picture is worth more than a thousand words. X-ray crystallography provides you with just that: pictures of the three-dimensional structures of molecules. "Ha-ras p21 is the first oncogene product whose molecular structure has been determined. This paper described the `on,' or active, form, in which the protein is complexed to a guanosine triphosphate. The results established that the chain fold of the p21 protein is very similar to that of the GDP-domain ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies